These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 6239839)

  • 61. Effects on murine trichinosis of niridazole, a suppressant of cellular but not humoral immunological responses.
    Grove DI; Warren KS
    Ann Trop Med Parasitol; 1976 Dec; 70(4):449-53. PubMed ID: 999358
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Peritoneal exudate T lymphocytes with specificity to sheep red blood cells. III. High dose of antigen induces suppressor T cells which influence the appearance in exudates of effector T cells for delayed-type hypersensitivity and helper T cells for humoral immune responses.
    Kaufmann SH; Ahmed JS; Chahin M; Hahn H
    Immunology; 1979 Nov; 38(3):613-9. PubMed ID: 160395
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Immunosuppressive properties of sera and urine dialysates from kidney-graft recipients treated with azathioprine, prednisolone, and niridazole.
    Jones BM; Bird M; Massey P; Millar D; Miller JJ; Reeves S; Salaman JR
    Br Med J; 1977 Sep; 2(6090):792-5. PubMed ID: 334335
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Systemic or local co-administration of lactoferrin with sensitizing dose of antigen enhances delayed type hypersensitivity in mice.
    Zimecki M; Kruzel ML
    Immunol Lett; 2000 Nov; 74(3):183-8. PubMed ID: 11064098
    [TBL] [Abstract][Full Text] [Related]  

  • 65. [Effect of trypsin on the development of a humoral immune response and of delayed hypersensitivity].
    Chalyĭ GA; Prokopenko LG
    Farmakol Toksikol; 1986; 49(3):71-4. PubMed ID: 2941314
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Cyclosporin A prevents suppression of delayed-type hypersensitivity in mice immunized with high-dose sheep erythrocytes.
    Webster LM; Thomson AW
    Immunology; 1987 Mar; 60(3):409-14. PubMed ID: 3570356
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Characterisation of cyclosporine-induced suppressor cells in murine delayed-type hypersensitivity responses.
    Mirisklavos A; Mottram PL; Dumble LJ; Clunie GJ
    Int Arch Allergy Appl Immunol; 1986; 79(2):215-9. PubMed ID: 2935501
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Effect of fractional cyclophosphamide dosage on sheep red blood cell-delayed-type hypersensitivity response in mice.
    Rondinone SN; Giovanniello OA; Barrios HA; Nota NR
    J Immunol; 1983 Apr; 130(4):1600-3. PubMed ID: 6220061
    [TBL] [Abstract][Full Text] [Related]  

  • 69. In vivo effect of prothymosin-alpha 1 on humoral and cell-mediated immune responses in the young rat.
    Marić D; Veljić J; Ranin J; Janković BD
    Int J Neurosci; 1991 Jul; 59(1-3):135-42. PubMed ID: 1837789
    [TBL] [Abstract][Full Text] [Related]  

  • 70. [Genetic restriction on interaction between the effects of delayed hypersensitivity and suppressor cells].
    Fontalin DN; Chernousov AD; Cherniakhovskaia IIu
    Biull Eksp Biol Med; 1981 Aug; 92(8):58-61. PubMed ID: 6457654
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Immunoregulation of lysozyme-specific suppression. II. Hen egg-white lysozyme-specific monoclonal suppressor T cell factor suppresses the afferent phase of delayed-type hypersensitivity and induces second-order suppressor T cells.
    Adorini L; Colizzi V; Doria G; Ricciardi-Castagnoli P
    Eur J Immunol; 1984 Sep; 14(9):826-30. PubMed ID: 6207031
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Low doses of chemotherapy to inhibit suppressor T cells.
    Berd D
    Prog Clin Biol Res; 1989; 288():449-58. PubMed ID: 2566177
    [No Abstract]   [Full Text] [Related]  

  • 73. Tumor bearer T cells suppress Bacillus Calmette-Guérin-potentiated antitumor responses. III. Identification of an auxiliary efferent suppressor-T-cell population.
    Hawrylko E; Mele CA
    Cell Immunol; 1984 Sep; 87(2):566-79. PubMed ID: 6235923
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Effects of Brazilin on induction of immunological tolerance by sheep red blood cells in C57BL/6 female mice.
    Mok MS; Jeon SD; Yang KM; So DS; Moon CK
    Arch Pharm Res; 1998 Dec; 21(6):769-73. PubMed ID: 9868554
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Lead intoxication impairs the generation of a delayed type hypersensitivity response.
    McCabe MJ; Singh KP; Reiners JJ
    Toxicology; 1999 Dec; 139(3):255-64. PubMed ID: 10647925
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Identification and purification of immunosuppressive activity in the urine of rats and a human patient treated with niridazole.
    Lucas SV; Daniels JC; Schubert RD; Simpson JM; Mahmoud AA; warren KS; David JR; Webster LT
    J Immunol; 1977 Feb; 118(2):418-22. PubMed ID: 320258
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Characterization of suppressor cells in anterior chamber-associated immune deviation (ACAID) induced by soluble antigen. Evidence of two functionally and phenotypically distinct T-suppressor cell populations.
    Wilbanks GA; Streilein JW
    Immunology; 1990 Nov; 71(3):383-9. PubMed ID: 1702748
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Immunoregulation in experimental interstitial nephritis: immunization with renal tubular antigen in incomplete Freund's adjuvant induces major histocompatibility complex-restricted, OX8+ suppressor T cells which are antigen-specific and inhibit the expression of disease.
    Kelly CJ; Clayman MD; Neilson EG
    J Immunol; 1986 Feb; 136(3):903-7. PubMed ID: 2416839
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Suppression of antigraft immunity by preimmunization. III. Characterization of suppressor T cells involved in suppression of the efferent phase of DTH against alloantigens.
    Bianchi AT; Hussaarts-Odijk LM; Wolters EA; Molendijk A; Benner R
    J Immunol; 1986 Jul; 137(2):433-42. PubMed ID: 2941481
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Inhibition of T suppressor cell function by local administration of an active cyclophosphamide derivative at the sensitization site.
    Limpens J; Scheper RJ
    Clin Exp Immunol; 1991 Jun; 84(3):383-8. PubMed ID: 1828396
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.